Regulations, Legislation & Enforcement

FDA photo

Cancer institute head named acting FDA chief

By Hank Schultz

Dr Ned Sharpless, MD, who is the current head of the National Cancer Institute, will be the interim head of the Food and Drug Administration when Dr Scott Gottlieb, MD, leaves next month.

Getty Images

FROM THE EDITOR'S DESK

Sloppy messaging on product performance misleads consumers

By FROM THE EDITOR'S DESK: Being honest about product performance

Transparency in the messaging around dietary supplements should include a level of honesty about claims made about product attributes.

Getty Images

MacKay leaves CRN for cannabis firm; Shao returns in interim role

By Hank Schultz

Andrew Shao, PhD, will replace Duffy MacKay, ND, as head of scientific and regulatory affairs at the Council for Responsible Nutrition in an interim role. MacKay is leaving the organization for a similar role at cannabis specialist CV Sciences.

FDA Commissioner Dr Scott Gottlieb, MD, testified before Congress on Wednesday.  Photo courtesy of FDA.

Gottlieb: FDA plans meeting in April on new CBD regulations

By Hank Schultz

FDA Commissioner Dr. Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. The goal is to create “an appropriately efficient and predictable regulatory framework for regulating CBD products,”...

Follow us

Featured Events

View more

Products

View more

Webinars